News Ionis claims first approval for Alexander disease therapy Ionis' Zanvastro has been approved by the FDA for Alexander disease, becoming the first disease-modifying therapy for the devastating rare disease.
News ViiV's Waterhouse exits to take the CEO job at CSL CSL has named Deborah Waterhouse as its new chief executive, on the same day her departure from the same role at ViiV was announced.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.